Health News Headline
U.S. Liver Transplants Declining
TUESDAY, May 22 (HealthDay News) -- The number of liver transplants in the United States has decreased since 2006, a new study finds.
Researchers said one reason for the decline is that harvesting livers after cardiac death has become more commonplace, and many of those livers end up being discarded after doctors determine the organs aren't healthy enough to attempt a transplant. Another reason livers are discarded is because of damage due to a condition known as fatty liver disease, which is associated with metabolic syndrome and high cholesterol.Read entire article...
Some others: Mohexal, Betatrex, Carafate, Darifenacine, Frusol, Levonorgestrela, Imovane, Decortisil, Risperidona, Doxaloc, Zirtek, Tobradistin, ...
Stivarga Approved for Liver Cancer
THURSDAY, April 27, 2017 (HealthDay News) -- U.S. Food and Drug Administration approval of the anti-cancer drug Stivarga (regorafenib) has been expanded to include liver cancer, the agency said Thursday in a news release.
Stivarga, among a class of drugs called kinase inhibitors, is designed to block enzymes that foster cancer growth. It's the first drug approved to treat liver cancer in nearly a decade, the FDA said.
"Limited treatment options are available for patients with liver cancer," said Dr. Richard Pazdur, acting director of the agency's Office of Hematology and Oncology Products. The drug was approved for people with liver cancer treated previously with the drug sorafenib.
More than 40,000 people in the United States are projected to be diagnosed this year with liver cancer, and nearly 29,000 will die from it, the National Cancer Institute estimates.Read entire article...